Temporary circulatory support for cardiogenic shock

Lancet
Alain CombesDaniel Brodie

Abstract

Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or from progression of long-standing underlying heart disease. When addressing the cause of underlying disease, the management of cardiogenic shock consists of vasopressors and inotropes; however, these agents can increase myocardial oxygen consumption, impair tissue perfusion, and are frequently ineffective. An alternative approach is to temporarily augment cardiac output using mechanical devices. The use of these devices-known as temporary circulatory support systems-has increased substantially in recent years, despite being expensive, resource intensive, associated with major complications, and lacking high-quality evidence to support their use. This Review summarises the physiological basis underlying the use of temporary circulatory support for cardiogenic shock, reviews the evidence informing indications and contraindications, addresses ethical considerations, and highlights the need for further research.

References

Mar 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·J KatoT Ito
Jun 18, 2005·Stroke; a Journal of Cerebral Circulation·Mark J AlbertsUNKNOWN Brain Attack Coalition
Jan 27, 2006·The New England Journal of Medicine·Ellen J MacKenzieDaniel O Scharfstein
Jun 8, 2006·JAMA : the Journal of the American Medical Association·Judith S HochmanUNKNOWN SHOCK Investigators
Mar 28, 2007·JAMA : the Journal of the American Medical Association·UNKNOWN TRIUMPH InvestigatorsJudith S Hochman
Jan 20, 2010·Journal of the American College of Cardiology·Krischan D SjauwJose P S Henriques
Jan 29, 2010·The Journal of Thoracic and Cardiovascular Surgery·Ardawan Julian RastanFriedrich Wilhelm Mohr
Mar 5, 2010·The New England Journal of Medicine·Daniel De BackerUNKNOWN SOAP II Investigators
Oct 19, 2010·Journal of the American College of Cardiology·Biswajit KarPranav Loyalka
Jul 9, 2011·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Hiroo TakayamaMathew R Williams
Aug 28, 2012·The New England Journal of Medicine·Holger ThieleUNKNOWN IABP-SHOCK II Trial Investigators
Sep 20, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthieu SchmidtAlain Combes
Oct 31, 2012·Circulation·Jennifer L PeuraUNKNOWN Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia
Mar 28, 2013·Critical Care : the Official Journal of the Critical Care Forum·Xavier RepesséCharles-Edouard Luyt
May 24, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·D W de LangeJ Meulenbelt
Sep 3, 2013·The New England Journal of Medicine·Ole FröbertUNKNOWN TASTE Trial
Sep 10, 2013·Lancet·Holger ThieleUNKNOWN Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators
Feb 28, 2014·Critical Care : the Official Journal of the Critical Care Forum·Darryl AbramsDaniel Brodie
May 13, 2014·Journal of the American College of Cardiology·Darryl AbramsDaniel Brodie
Jul 26, 2014·American Journal of Respiratory and Critical Care Medicine·Alain CombesUNKNOWN International ECMO Network (ECMONet)
Oct 4, 2014·Journal of the American College of Cardiology·Robert StretchPramod Bonde
Jan 7, 2015·Journal of the American Heart Association·Shahzad ShaefiSajid Shahul
Mar 10, 2015·The Journal of Thoracic and Cardiovascular Surgery·Hiroo TakayamaYoshifumi Naka
Mar 31, 2015·European Journal of Heart Failure·Veli-Pekka HarjolaUNKNOWN GREAT network
Sep 30, 2015·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Amit BadiyeSandra Chaparro

❮ Previous
Next ❯

Citations

Aug 23, 2020·Journal of Cardiovascular Pharmacology·Giuseppe Biondi-ZoccaiFrancesco Versaci
Feb 9, 2021·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Michael Joner, Hendrik B Sager
Mar 9, 2021·Anaesthesia·A de MarvaoS Price
Feb 19, 2021·Seminars in Thoracic and Cardiovascular Surgery·Amy French, Neel R Sodha
Mar 4, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Jenelle BadulakUNKNOWN ELSO COVID-19 Working Group Members
May 1, 2021·Current Opinion in Critical Care·Daniel Rob, Jan Bělohlávek
Jul 22, 2021·Future Healthcare Journal·Virginia NewcombeMervyn Singer
Jul 23, 2021·Critical Care : the Official Journal of the Critical Care Forum·Alexandra SchouMarc Sørensen
Aug 5, 2021·The New England Journal of Medicine·Rebecca MathewBenjamin Hibbert
Aug 10, 2021·Heart Failure Reviews·Einar Gude, Arnt E Fiane
Aug 17, 2021·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Cameron UpchurchRobert G Hendrickson
Aug 28, 2021·European Heart Journal·Theresa A McDonaghUNKNOWN ESC Scientific Document Group
Sep 11, 2021·Intensive Care Medicine·Darryl AbramsDaniel Brodie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.